Topigen Pharmaceuticals Inc. and Novagali Pharma Enter Into Strategic Collaboration for Allergic Ocular Diseases and Allergic Rhinitis
MONTREAL and EVRY, FRANCE -- (MARKET WIRE) -- March 22, 2007 -- TOPIGEN Pharmaceuticals Inc., a development stage biopharmaceutical company specializing in respiratory disorders, and NOVAGALI Pharma S.A., a specialty biopharmaceutical company developing novel ophthalmic products, today announced the initiation of a strategic collaboration and cross-license agreement.